Navana Pharmaceuticals PLC announcements
122 Dhaka Stock Exchange announcements for Navana Pharmaceuticals PLC (NAVANAPHAR) since 2022: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (12).
- Resumption after record date
Trading of the shares of the Company will resume on 29.11.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 28.11.2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 24.11.2022 to 27.11.2022. Trading of the shares of the Company will remain suspended on record date i.e., 28.11.2022.
- Q1 Financials
(Continuation news of NAVANAPHAR): NOCFPS has increased due to the growth in business volume and efficient utilization of working capital supported by higher receipt from other income. (end)
The first part of this announcement is missing from the archive. - Emphasis of matters
(Continuation news of NAVANAPHAR): of BDT 93.5/$1 on 30 June 2022 as per the requirements of IAS 21 - The Effects of Changes in Foreign Exchange Rate. Subsequently, up to 30 September 2022, foreign currency liabilities have been settled at the average rate of BDT 102.15/$1 as disclosed under Event after Reporting Period as per IAS 10 in note # 37.00 to the financial statements of the company. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the company has informed that a meeting of the Board of Directors will be held on November 13, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the company for the First Quarter (Q1) period ended September 30, 2022.
- Update of Information
(Continuation news of NAVANAPHAR): The brokerage houses & merchant bankers are also requested to provide their Bank Account Name, Number, Routing number etc. on or before 10 December 2022. (end)
The first part of this announcement is missing from the archive. - Dividend Declaration
The Board of Directors has recommended 11% Cash Dividend for the year ended June 30, 2022. Date of AGM: 22.12.2022, Time: 12.00 PM, Venue: Digital Platform. Record Date: 28.11.2022. The Company has also reported EPS of Tk. 3.42, NAV per share of Tk. 43.41 and NOCFPS of Tk. 2.48 for the year ended June 30, 2022 as against Tk. 2.52, Tk. 41.19 and Tk. 1.52 respectively for the same period of the previous year.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (30.10.2022) following its corporate declaration. However, as per the BSEC Order No. BSEC/CMRRCD/2001-07/39 dated July 28, 2022, the floor price shall be applicable accordingly.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2022 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- Q3 Financials
(Continuation news of NAVANAPHAR): Moreover, profit after tax was BDT 191.84 million and basic EPS of BDT 2.39 for the 09 (nine) months (July 2021- March 2022) period ended on 31 March 2022 as against profit after tax of BDT 132.39 million and basic EPS of BDT 1.65 for the same period of the previous year. However, Post-IPO EPS would be BDT 1.79 for 09 (nine) months (July 2021- March 2022) period ended on 31 March 2022. (cont.2)
The first part of this announcement is missing from the archive. - Prohibition on providing loan facilities to purchase securities
DSE NEWS: The Stock Brokers, Merchant Bankers and Portfolio Managers are requested to abstain from providing loan facilities to purchase securities of Navana Pharmaceuticals Limited in between 1st to 30th trading day starting from today i.e. October 18, 2022 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.